Metabolomics approaches in pancreatic adenocarcinoma: tumor metabolism profiling predicts clinical outcome of patients

BACKGROUND: Pancreatic adenocarcinomas (PAs) have very poor prognoses even when surgery is possible. Currently, there are no tissular biomarkers to predict long-term survival in patients with PA. The aims of this study were to (1) describe the metabolome of pancreatic parenchyma (PP) and PA, (2) det...

Descripción completa

Detalles Bibliográficos
Autores principales: Battini, S., Faitot, F., Imperiale, A., Cicek, A. E., Heimburger, C., Averous, G., Bachellier, P., Namer, I. J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5353864/
https://www.ncbi.nlm.nih.gov/pubmed/28298227
http://dx.doi.org/10.1186/s12916-017-0810-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5353864/
https://www.ncbi.nlm.nih.gov/pubmed/28298227
http://dx.doi.org/10.1186/s12916-017-0810-z

Ejemplares similares